Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Clinical characteristics of asthmatic patients prescribed various beta-agonist metered-dose inhalers at Yamagata University Hospital
Autore:
Ojima, F; Nakamura, H; Ebihara, M; Shoji, T; Tomike, H; Nakagawa, Y;
Indirizzi:
Yamagata Univ Hosp, Dept Pharm, Yamagata 9909585, Japan Yamagata Univ Hosp Yamagata Japan 9909585 Pharm, Yamagata 9909585, Japan Yamagata Univ, Sch Med, Dept Internal Med 2, Yamagata 9909585, Japan Yamagata Univ Yamagata Japan 9909585 rnal Med 2, Yamagata 9909585, Japan
Titolo Testata:
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
fascicolo: 1, volume: 121, anno: 2001,
pagine: 79 - 84
SICI:
0031-6903(200101)121:1<79:CCOAPP>2.0.ZU;2-X
Fonte:
ISI
Lingua:
ENG
Soggetto:
NEW-ZEALAND; FENOTEROL; DEATH; MORTALITY;
Keywords:
beta-agonist metered-dose inhaler; clinical characteristics; pharmaceutical instruction; asthmatic patients;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Life Sciences
Citazioni:
20
Recensione:
Indirizzi per estratti:
Indirizzo: Ojima, F Yamagata Univ Hosp, Dept Pharm, Yamagata 9909585, Japan Yamagata Univ Hosp Yamagata Japan 9909585 magata 9909585, Japan
Citazione:
F. Ojima et al., "Clinical characteristics of asthmatic patients prescribed various beta-agonist metered-dose inhalers at Yamagata University Hospital", YAKUGAKU ZA, 121(1), 2001, pp. 79-84

Abstract

To determine the prescription characteristics of beta -agonist metered-dose inhalers (MDI), we retrospectively investigated all prescriptions containing one of five types of beta -agonist MDIs available at Yamagata University Hospital in 1997, as well as patients' characteristics. The total number of asthmatic patients was 225 (age, 11-79, mean, 47.2) in 1997. Fenoterol MDI was prescribed to patients who visited the hospital at regular periods and had more severe asthma. Isoprenaline MDI also was not prescribed for first-time patients. Patients who were prescribed tulobuterol MDI had mild or moderate asthma and some of them were only occasional or first-time visitors. Salbutamol and procaterol MDIs were also prescribed for first-time patients; however, tulobuterol MDI was the most frequently prescribed for first-time patients. Patients prescribed fenoterol and isoprenaline MDIs had adequate knowledge of proper asthma management, because sufficient information had been provided about the use of MDIs in the past. Patients prescribed tulobuterol MDI should be provided with detailed instructions because they had little knowledge of handling MDIs and selfmanagement of asthma as many ofthem were first or intermittent visitors. Patients prescribed salbutamol or procaterol MDIs should be evaluated regarding their past medications and some of them should be instructed regarding the use of the MDI. Although these clinical aspects might be applicable only to our hospital, the same or other prescription patterns will be found in other hospitals and/or by other physicians. Adequate instructions to individual patients who are prescribed a particular beta -agonist MDI should be provided by the medical staff, especially to outpatients, to reduce hospitalization and death from asthma.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/06/20 alle ore 09:49:18